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Currently, to measure the amount of mRNA produced during transcription, a post transcription 
assay is required, such as gel electrophoresis or reverse transcription- quantitative polymerase 
chain reaction (RT-qPCR) which all require RNA purification steps. Both methods are subject 
to high error and in addition, RT-qPCR is a long process which can take hours to run. This 
study describes a method in which post transcriptional mRNA can be qualitatively measured 
between reaction conditions or quantitatively measured after calibration. The post transcription 
assay utilises a fluorescent Escherichia coli single stranded binding protein (SSB). In this 
study, SSB showed similar binding properties to mRNA, to that of its native substrate, ssDNA. 
A mutant of SSB -SSB G26C- used in previous studies, was fluorescently labelled with 7-
Diethylamino-3-((((2-Maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC). A fluorescence 
increase occurs when the SSB is bound to both ssDNA and ssRNA, and this increase is 
dependent on substrate concentration. This study shows the MDCC-SSB can be used as a 
comparative measurement of mRNA concentrations following in vitro transcription. After 
finding this method unsuitable for real time studies, we investigated potential causes for this 











Chapter 1: Introduction  
 
1.1 Transcription and its importance 
 
Transcription is the decoding of the DNA into RNA and is at the cornerstone of a cells survival. For 
transcription to occur large protein complexes are required and transcription factors are needed to 
direct the transcription. The main component of transcription is the RNA polymerase and in 
eukaryotes, there are three - RNA polymerase I, II and III. Each of these polymerases are responsible 
for the production of different types of RNAs. rRNA is transcribed by RNA polymerase I1,2, RNA 
polymerase II is responsible for transcribing mRNA, miRNA and other certain types of messenger 
RNA2,3 whilst finally RNA polymerase III transcribes tRNA molecules2,4. All three RNA polymerases have 
different distributions within the nucleus; RNAPI is found in the nucleoli5, whilst the remaining two 
are found in discrete sites around the nucleoplasm6,7. If errors occur within this transcription phase, 
cells can begin to form tumours8 and long non-coding RNAs can lead to certain cancers9. For this 
reason, this makes transcription an important process to study and it is vital to understand the role of 
every components. One example would be myosin, a known component of transcription machinery, 
whose role is yet to be understood 10 and so new methods to characterise this element, are necessary. 
The aim of this study is to produce a reagentless mRNA biosensor that can be used to study 
transcription in vitro, allowing for the rapid and accurate report on polymerase activity, in controlled 
conditions. 
1.2 The process of transcription 
 
Transcription is a process that can be broken into three major stages; initiation, elongation and finally 
termination. Initiation occurs when an RNA polymerase is recruited to a set promotor sequence within 
the DNA. This recruitment occurs through interactions with specific transcription factors. In the case 
of the eukaryotic RNA polymerase II, transcription factors such as TFIIA,TFIIB, TFIID, TFIIE, TFIIF and 
TFIIH  lead to the formation of the preinitiation complex11 (figure 1.1). This complex of RNA polymerase 
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and transcription factors is able to trap the promotor DNA open12. The RNA polymerase is then 
released from the promotor sequence through various mechanisms, such as interactions of the 
capping enzyme13 and transcription factor interactions including ATP hydrolysis14. During this period 
of time the RNAP undergoes repetitive abortive initiation, producing small RNA molecules. Once this 
newly synthesised RNA reaches a length of approximately 9-11 nucleotides long it enters the 





Figure 1.1 Diagram showing initiation complex of RNA polymerase II. RNA polymerase II is recruited 
to the DNA by the array of transcription factors which first bind to the DNA promotor sequence. 
Adapted from Bywater et al., (2013).16 
 
The elongation stage is made up of a simpler complex in which, as RNAPII travels along the DNA 
template, the DNA becomes unwound within the transcript bubble of RNAPII. Nucleoside 
triphosphates (NTPs) are then polymerised by the RNAPII, forming the RNA transcript from the 
unwound DNA template (figure 1.2). RNAPII also requires the elongation factors  TFIIF and TFIIS which 
aid in transcript cleavage, as well as relieving arrest of the RNAPII17. Once elongation is completed and 
the RNAPII reaches a termination sequence, the process is terminated and the RNA transcript is then 
released.  This RNAPII transcription process produces a complete mRNA transcript that contains at 












Figure 1.2. Diagram of RNAPII during elongation. Downstream DNA enters from the right of the 
diagram as NTPs enter from below. Polymerisation of the NTPs occur in the centre of the protein and 
the mRNA transcript in red exits towards the back of the diagram. Diagram adapted from Bushnell, 
Cramer and Kornberg (2001)18. 
1.3 In vitro transcription 
 
To understand which components are required for transcription it is possible to remove them one by 
one. However, in cells due to their multi part nature, this strategy could lead to complete cell failure 
through various mechanisms rather than being directly caused by the loss of transcription machinery. 
Therefore, in vitro transcription assays allow for these removal and addition assays without the 
complexity of the whole nucleus. Transcription kits were first used to produce RNAs back in the late 
19 ? ? ?Ɛ19, utilising simple prokaryotic systems. These assays allow laboratories to produce in house 
RNA to be used for structural analysis as well as RNAi20 and the reprogramming of cells to 
pluripotency21. It also focuses on the basic requirements for transcription and removes the excess 
nuclear environment, allowing for the study of transcription and the activity of the RNA polymerase 
only. Three basic prokaryotic polymerases have been well characterised for in vitro transcription. The 
E. Coli phages T322 and T723, and S. typhimurium SP6 polymerases24. Within this study the T7 
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polymerase has been employed to act as our model of transcription ensuring the assay works before 
applying it to an in vitro eukaryotic transcription assay. Eukaryotic transcription assays are slightly 
different due to the fact they rely on nuclear extracts that are able to undergo RNA polymerase II 
transcription through different selective measures25, but this system still contains unnecessary 
impurities and uncharacterised components.   
 
1.4 RNA quantification to study in vitro transcription  
 
The classical methods to study in vitro transcription, detect the presence or quantify the mRNA 
transcripts produced. In high yielding transcription assays such as the T7 polymerase, the presence of 
mRNA can be shown by undergoing RNA purification and then separating the transcripts using agarose 
gel electrophoresis, followed by staining with a common nucleotide stain such as SYBR®Gold 
(Invitrogen, Rochford UK). If the analysis requires quantification of RNA a simple nanodrop is able to 
measure nucleic acid concentration and purity through the absorptions between wavelengths 230nm-
340nm26. However, for both these methods samples need to undergo RNA purification to remove both 
proteins and DNA from the solution, this always leads to loss of total RNA yield. The methods described 
require high yields of mRNA product and therefore are not suitable for eukaryotic transcription assays. 
The use of radioactively tagged nucleotides and quantitative PCR (qPCR) are the two most common 
methods to measure eukaryotic in vitro transcription. Isotopically labelled 32P (phosphorous) is a 
common label incorporated into nucleotides that are assimilated into mRNA during in vitro 
transcription and allows for the quantification of transcript produced27, this method though can be 
costly and requires appropriate safety gear as well as a scintillation counter. There are slight variations 
of qPCR; however, one method, reverse transcription quantitative PCR (RT-qPCR) is able to utilise 
specific fluorescently tagged primers that bind to the cDNA, produced from the reverse transcription 
of the mRNA transcribed, during PCR28. Once again, this method has drawbacks due to the multi-step 
process for purifying mRNA, the design of primers and the reverse transcription step, all of which takes 
time and can cause the loss of transcribed mRNA.  More modern approaches such as QuantiGene is a 
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multi-step process in which the mRNA samples do not need to be purified but are trapped to 
framework and then probed and stained29.  Quant-ŝd ?ZŝďŽ'ƌĞĞŶ ?ZEƌĞĂŐĞŶƚ, another modern 
approach to mRNA quantification, is a dye that relies on the fluorescence increase of around 1000-
fold when bound to RNA and results in an RNA concentration dependent fluorescence increase30. All 
methods stated, except for that of the QuantiGene, require mRNA purification and none of them are 
able to study transcription in real time. 
1.5 Methods to study transcription activity in real time 
 
To fully understand the transcription process it is vital to study it in real time. If transcription could be 
followed in real time, it would be possible to design experiments in which, with the addition of 
inhibitors, the removal of transcription factors or the varying of other necessary components, allowing 
for the immediate effects on transcription to be analysed. As previously discussed, RNA quantification 
takes brief snap shots of the transcription process and so, depending on the timing of these snapshots, 
different phases of transcription could be misconstrued. Currently there are few accessible methods 
to study transcription in real time in vitro and so it is necessary to look at in vivo methods to present 
an in vitro method. RNA transcription can be visualised in vivo through light up and FRET aptamers31,32. 
These consist of designed nucleic acids able to bind tightly to RNA, causing a visible fluorescence 
increase. This method allows us to trace RNA progression through cells and can provides a total 
amount of the specified RNA being transcribed. Nuclear run-on analysis33 of transcription provides 
direct measurement of one gene and utilises RNA polymerase II to incorporate radioactive nucleotides 
into the gene. The amount of incorporation reflects a direct link to transcriptional activity of RNA 
polymerase II on that specific gene similar to that of the in vitro method. This method however 
requires complete and isolated nuclei and of course uses potentially harmful and expensive 
radioactive substances. Whilst all of these methods are in vivo very little has been designed to measure 
in vitro ǁŚĞƌĞĐŽŶĚŝƚŝŽŶƐĂŶĚƚƌĂŶƐĐƌŝƉƚŝŽŶĐŽŵƉŽŶĞŶƚƐĐĂŶďĞĐŽŶƚƌŽůůĞĚ ? ? ?-O-methylribonucleotide 
molecular beacons have been used in vitro to study transcription of different RNA polymerases34. This 
method requires specifically designed beacons to be synthesised to match the known transcript. As 
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well as specific synthesis, the beacons require unnatural amino acids which are expensive and hard to 
synthesise. Binary probes as a FRET pair is method that has been built on molecular beacons to 
measure transcription activity in vitro and in real, these are created to specifically bind to either the 
 ? ? Žƌ  ? ? hdZ ĂŶĚ ƵƐĞ Ǉ ? ĂŶĚ Ǉ ? ĂƐ &Zd ĨůƵŽƌŽƉŚŽƌĞƐ35. This real time method does show 
transcriptional activity through mRNA production and whilst ƌĞůŝĞƐůĞƐƐŽŶŐĞŶĞƐƉĞĐŝĨŝĐŝƚǇ ?ŝƚƐ ?&Zd
signal depends on the UTR sequence used and its environment due to varying degrees of hybridisation. 
None of these methods are reagentless and they have large variations of results depending on the 
mRNA transcript.   
 
1.6 The differences between RNA and DNA 
 
To produce a biosensor and a protocol that is able to distinguish between the different components 
present in the transcription solution, it is important to understand the differences between the mRNA 
transcript and the DNA template. As previously mentioned it is already possible to quantify RNA and 
DNA independently; however, some methods are unable to distinguish either between the two or 
between the different varieties of RNA. Loss of the sĞĐŽŶĚĂůĐŽŚŽůŐƌŽƵƉŽŶƚŚĞ ? ?ŽĨƚŚĞƌŝďŽƐĞƐƵŐĂƌ
and replacement it with a simple hydrogen results in simple ribose sugar which is the difference 
between DNA and RNA and it is this difference that leads to their significantly separate roles. It is 
because of these differences that it is vital to segregate the two when undergoing in vitro 
quantification of RNA. Whilst UV quantification is rapid and easy it is unable to distinguish between 
RNA and DNA and is only able to measure total nucleotide concentration. To ensure reliable 
concentration readings the RNA needs to be purified. As both single stranded and double stranded 
nucleic acids are present in transcription, it is a must to create a biosensor that can be specific only to 
the single stranded nucleic acids- mRNA. Most common nucleic dyes to quantify RNA struggle to 
differentiate between DNA and RNA. Secondly, if possible the sensor needs to identify specifically 
mRNA and not any other forms such as tRNA. This is where the RiboGreen® dye has its downfall as it 
is able to bind to all forms of RNA30. We wish to distinguish between all of these because the mRNA 
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concentration reflects solely on the polymerase activity and should be the only measurable variable 
in the system. The in vitro eukaryotic transcription systems could potentially have various RNA species 
that could cause false positives, if the RiboGreen® was used. 
1.7 Working with fluorescence. 
 
The use of fluorescence as a technique has increased rapidly in recent years due to its particular 
properties and has been employed in this study. Fluorescence is used from imaging36, to measuring 
kinetics of binding partners37 and to acting as a sensor for certain substrates38. Fluorescence is so 
widely applied for various reasons: it is a much safer choice over radioactively labelled options that 
require appropriate containment and disposal, and it has a high sensitivity within biochemical assays 
that allow measurements of protein interactions from micromolar to low picomolar39,40. The signals 
are rapid, allowing sensitive single molecule studies. Single molecule studies use fluorescence to 
visualise single interactions and association kinetics of proteins binding to their specific substrates, 
such as the recruitment of fluorescently tagged transcription factors to DNA41. When using a 
fluorescent marker for any of these techniques, various qualities have to be assessed. Fluorescence is 
emitted from a molecule after it has been excited by absorbing a photon, as it releases the photon 
and returns to its ground state it emits fluorescence at a longer, lower energy wavelength than 















Figure 1.3. Jablonski energy diagram of fluorescence. Absorbance of a photon takes a femto-second, 
energy is absorbed by the molecule and the photo is released at a lower energy wavelength taking 
approximately a nano-second. Taken from Fili & Toseland. (2014)42. 
 
 When first evaluating the fluorescence of a molecule it is important to define its excitation and 
emission wavelengths and ensure the Stokes shift is appropriate for its application. Stokes shift is the 
difference between the excitation and emission maximum wavelengths, if these are too similar it is 
not possible to detect the emission without large background readings from the exciting light source. 
This can mean that different instrumentation such as bulbs and filters may need to be altered. 
Secondly, when deciding on fluorescent molecules the life-time of the emission and the stability of 
the fluorophore need to be taken into consideration. Bleaching of fluorophores can occur over time 
and so the fluorescent signal can reduce, giving false or incorrect measurements which is of particular 
importance for slow processes. Finally, brightness needs to be considered, if the dye is used for 
imaging, then a much brighter dye is required compared to that used in stopped flow where brightness 
of a fluorophore can lower. In this study the thiol reactive coumarin dye 7-Diethylamino-3-((((2-
Maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC) was deemed a suitable fluorophore as it is very 
stable. Whilst it is not ideal for microscopy due to its poor photopysical properties, it is suitable for 
more sensitive biochemical studies.  
16 
 
1.8 Current fluorescent biosensors  
 
Biosensors have been defined by IUPAC ĂƐ “a specific type of chemical sensor comprising a biological 
or biologically derived recognition element, ?43 and, like with any type of sensor, is comprised of two 
elements. The first being the recognition element, this needs to be able to specifically recognise the 
substrate and have some interaction with it. The remaining component is the transducer, which leads 
to a measurable signal, in the case of this study, the transducer is the fluorescent molecule. In the case 
of biosensors, often the biological component is the recognition element which can be derived from 
proteins44, aptamers45 and anti-bodies46. In this study a protein based biosensor has been created and 
so will be the focus from now on. Protein based biosensors utilise the highly evolved specificity that 
has already been well characterised for that protein. For example in the production of an inorganic 
phosphate biosensor Brune et al47 manipulated the specificity of the phosphate binding protein and 
attached a fluorescent dye. As a result, once the protein was bound to an inorganic phosphate (Pi), a 
13 fold increase in fluorescence intensity was observed and this was later used to measure the activity 
of actomyosin subfragment 1 ATPase48. Another example of where proteins have been selected for 
their specificity was in the production of a real time biosensor for helicase activity. Dillingham et al49 
used the single stranded binding protein from E. coli tagged with a fluorescent dye, that bound to 
single stranded DNA as the helicase PcrA unwound dsDNA. This allowed helicase activity and the speed 
of which it unwound dsDNA to be measured in a reagentless fashion and in real time. This was then 
taken a step further with helicase activity being visualised in single molecule studies50. By requiring 
only the protein to be in the sample mixture and no other extra reagents necessary it is possible to 
keep the conditions near native and with SSB being naturally found in the cell it does not intervene 
with the helicase process. From these previous studies we have wanted to apply the same tactics used 





1.9 What is SSB? 
 
To ensure the SSB was an appropriate protein to use as an mRNA fluorescence biosensor it is 
important to understand its stability and interactions in different environments. E. coli SSB is a well 
characterised protein that is homo-tetrameric and contains 4 OB-fold domains51. Oligonucleotide 
binding folds (OB-folds)  can be ɴ-barrels consisting of 5 highly coiůĞĚĂŶƚŝƉĂƌĂůůĞůɴƐŚĞĞƚƐ and  vary in 
length across OB-fold containing proteins, as well as this they also have a very low degree of similarity 
in their sequence between themselves52. There is one of these OB-fold domains, responsible for the 
ssDNA binding of each monomer. These monomers are each 18.9kDa large. One main use for SSB in 
the cell is that its C-terminal binding domains have shown to be the biologically important domains 
responsible for DNA replication and repair53. The formation and binding properties of SSB vary 
depending on the surrounding conditions. It has two main binding modes, known as (SSB)65 and 
(SSB)35, which have been well characterised by Lohman et al 54. In high salt concentrations above 
200mM NaCl SSB binds to ssDNA in the form of (SSB)65, this means that all four OB-folds are bound to 
ssDNA. This case is also true when the nucleotide length is approximately 65 nucleotides long, causing 
the ssDNA to wrap completely around the protein. (SSB)35 however is a different bonding mode where 
the ssDNA wraps only around half of the protein and interacts with only two of the four OB-folds. This 
binding mode occurs in low salt concentrations less than 200mM NaCl and when the nucleotide length 
is around 3555 as shown in figure 1.4. In the case of (SSB)35 it is possible for two ssDNA molecules that 
are 35 nucleotides long are able to bind to one SSB tetramer56. It has recently been shown that both 




Figure 1.4. SSB in its bound states. a) (SSB)65 bound to ssDNA with full wrapping and all four OB-folds 
interacting. b) (SSB)35 bound to ssDNA with half wrapping and only two OB-folds interacting showing 
ƚŚĞ ? ?ďĞůŽǁƚŚĞƉƌŽƚĞŝŶĂŶĚ ? ?ĂďŽǀĞĐŽŵƉĂƌĞĚƚŽ(SSB)65 where both ends are adjacent. Taken from 
Raghunathan et al., (2000)58. 
 
(SSB)35 is able to undergo what has been classified as unlimited cooperativity with ssDNA, which is the 
formation of proteins lined along the piece of ssDNA. (SSB)65 undergoes limited cooperativity because 
all four OB-fold interactions lead to an irregular pattern of dimerised proteins (figure 1.5)59. All of these 
binding modes need to be taken into account when using SSB as a biosensor, as depending the 
placement of the fluorophore and its local environment can all have an effect on the fluorescence 
change that could occur. SSB has also shown to have incredibly tight binding to ssDNA60 and, whilst 
not as tightly as with ssDNA, SSB is also able to bind to RNA of different lengths and types, with varying 
strengths61. Due to these different binding modes and the varying salt concentrations in transcription 
assays, it is important to consider both binding modes when preparing the biosensor. 








Figure 1.5. Two types of cooperativity of SSB bound to ssDNA. a) Limited cooperativity of (SSB)65 
shown with only formation of dimer tetramers. b) Unlimited cooperativity of (SSB)35 able to bind 
repetitively adjacent to each other. Adapted from Lohman, T. M. & Ferrari M. E. (1994).54 
 
1.10 How has it been used previously?  
 
As previously mentioned, SSB has already been used as a biosensor to report on the unwinding of 
helicases. By carrying on the previous work done by Dillingham et al49, this study will use the same 
point mutated SSB in which a glycine residue is replaced by a cysteine residue at the 26th position. This 
mutation does not affect the binding of SSB or the formation of its tetrameric shape49. When SSB is 
referred to in this study, it is assumed the reference is to the G26C mutant. This mutation allows for 
the thiol reactive fluorophore N-[2-(iodoacetamido)ethyl]-7-diethylaminocoumarin-3-carboxamide) 
(IDCC) to be attached. By having the fluorescent dye at this position, a fluorescence increase was 
observed by Dillingham et al.49, due changes in the local environment, when SSB binds to ssDNA. 
Whilst IDCC is not currently available from manufacturers, in this study the commercially available 
fluorophore, MDCC was used to ensure the mRNA biosensor is easy to produce. Both dyes are 
comprised of the same functional groups, however, MDCC comes in two isomers compared to IDCC 
which is a completely fixed structure. The fluorescence properties of both MDCC isomers have not 
been characterised separately and, therefore may vary between each other, leading to a variation of 







This study aims to build upon previous ideas and methods to show that SSB, whilst already proven to 
be a strong reagentless biosensor for ssDNA , can also be used to measure mRNA concentration. This 
will allow for the real time analysis of RNA polymerases as shown in figure 1.6 and the production of 
a biosensor that can be produced relatively cheaply without any specialist equipment. 
This project can be broken down into the following definitive aims: 
1) Characterise SSB ssRNA binding.  
2) Utilise MDCC-SSB as a post transcription biosensor to qualitatively analyse the concentration 
of mRNA so as to act as a quick and easy mRNA measurement method.  
3) Show that calibration can be undertaken with MDCC-SSB to allow for the quantification of 
mRNA in transcription samples. 
4) To use MDCC-SSB in a real time transcription assay allowing the RNA polymerase activity to 









Figure 1.6. A schematic to show MDCC-SSB in green increasing in fluorescence when bound to 










Unless stated otherwise all reagents were purchased from Sigma Aldrich (Dorset, UK). 
2.2 Plasmids used 
 
Plasmid Type Marker Supplier 
G26C SSB pET28 (No tag) Ampicillin Provided by Dillingham 
et al49 

















Figure 2.1. Plasmid map of pET28. The plasmid was provided by Dillingham et al,.49 with the gene 




















Figure 2.2. Plasmid map of pET151. The plasmid was purchased from Life Technologies (California, 
USA) with a histidine labelled G26c SSB inserted between the T7 promotor and terminator.  
 
2.3 Oligonucleotides used. 
 



















 ? ?&ůƵŽƌĞƐĐĞŝŶ Sigma Aldrich, 
Dorset, UK 
Fluorescein ssDNA40  TTAGTTGTTCGTAGTGCTCGTCTGGCTCT
GGATTACCCGC* 
 








2.4 Expression of SSB 
 
E.coli BL21 competent cells were transformed with the designated vector using the heat-shock 
method62 and were grown overnight in Lysogeny Broth (LB) with 100 µg. mL-1 ampicillin Ăƚ ? ?ȗC and at 
280 rpm. A 10mL aliquot of cells were then placed into 1 litre of fresh LB with 100 µg. mL-1 ampicillin 
and allowed to grow in the same conditions until a cell OD600 of 0.6 was reached. Cells were then 
induced with 1mM IPTG. After induction cells were grŽǁŶŽǀĞƌŶŝŐŚƚĂƚ ? ?ȗC. Cells were centrifuged 
Ăƚ  ? ? ? ?ƌƉŵĨŽƌ  ? ?ŵŝŶƵƚĞƐĂƚ  ?ȗĂŶĚƌĞƐƵƐƉĞŶĚĞĚŝŶƌĞƐƵƐƉĞŶƐŝŽŶďƵĨĨĞƌ  ? ? ?ŵDdƌŝƐ ?,ůƉ, ? ? ? ?
40mM imidazole, 200mM NaCl, 1mM DTT and 20% sucrose) and 0.1mM PMSF and stored at - ? ?ȗ ? 
2.5 Eletrophoretic Mobility Shift Assay (EMSA) 
 
50nM SSB was incubated with 250nM ssDNA70 or ssRNA70 for 20 minutes at room temperature in 
50mM Tris.HCl pH 7.5, 100mM NaCl, 3mM MgCl2. Samples were loaded onto an acrylamide gel (12% 
acrylamide, Tris. Boric acid pH 7.5) (TB) and ran in TB buffer. SYBR®Gold (Invitrogen, Rochford, UK) 
stained the nucleic acids following the ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ instructions.  
2.6 Tryptophan fluorescence titration 
  
10nM of ssDNA70 or ssRNA70 ǁĞƌĞƚŝƚƌĂƚĞĚŝŶƚŽ ? ? ?ŶD^^Ăƚ ? ?ȗŝŶ ? ?ŵDdƌŝƐ ?,ůƉ ? ? ? ?100mM 
NaCl or 200mM NaCl as defined and 2mM MgCl2. Tryptophan fluorescence was measured using a Cary 
Eclipse Fluorescence Spectrophotometer (Agilent, Edinburgh, UK) at excitation 285nm and emission 
at 325nm. To calculate fluorescence quenched (%) used equation 1. 
 
Equation 1)     ܨ݈ݑ݋ݎ݁ݏܿ݁݊ܿ݁ݍݑ݄݁݊ܿ݁݀ሺ ?ሻ ൌ  ி೔ൈ஽ி೔ிబ ൈ  ? ? ? 
Where F0 is initial fluorescence intensity, Fi is the intensity after titration and DFI is the dilution factor 
from the titration. The titration curves were fit with two linear regression lines using Grafit (Erathicus, 
Horley, UK) and their interception calculated.  
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2.7 Nanotemper Tryptophan florescence titration 
 
200nM SSB was incubated with 16 capillaries containing varying concentrations of substrate as 
defined from 1µM to 0.1nM at room temperature in 1X Phosphate buffer saline (PBS). Tryptophan 
quenching was measured using the Monolith NT. Label free fluorometer (NanoTemper technologies, 
Munich, Germany) at room temperature whilst under supervision from a representative of the 
company. The result was presented by the representative after using software provided.  
2.8 Titration of SSB into fluorescein nucleotides. 
 
100µl of 1µM fluorescein nucleotides of varying length and type (table 2.2) were aliquoted into a 96 
well plate and serial diluted with SSB (1-0µM) in 50mM Tris.HCl pH 7.5, 100mM NaCl, 3mM MgCl2. The 
fluorescein was excited at 489nm and fluorescence was measured using a ClarioStar microplate reader 
(BMG LabTech, Ayelsbury, UK) from 520nm to 600nm. The fluorescence intensity was corrected for 
dilutions and then normalized, with the highest intensity being 1.  
2.9 Labelling SSB monomers with MDCC 
 
The labelling method has been adapted from Dillingham et al49. 3mg of SSB was incubated with 1M 
DTT for 20 minutes at room temperature. A PD10 column (GE Healthcare, Little Chalfont, UK) was 
equilibrated in 20mL of 20mM Tris.HCl pH 7.5, 1mM EDTA, 500mM NaCl and 20% glycerol. After DTT 
incubation the solution was loaded onto the column and the column was eluted with the same buffer. 
The A280 was measured for each fraction and samples containing SSB were pooled together. 2 fold 
molar excess of MDCC was added and incubated at defined conditions with end over end mixing and 
in protection from light. A new PD10 column was equilibrated in 20mL of 20mM Tris.HCl pH 7.5, 1mM 
EDTA, 500mM NaCl and 20% glycerol and the MDCC-SSB was loaded onto the column, and washed 
and eluted using the previous buffer removing any excess MDCC. The concentration of SSB was taken 
using A280 absorption with extinction coefficient of ɸ = 28,500 cm-1 M-1 per monomer and MDCC 
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concentration was taken using absorption at 435nm and the extinction coefficient is assumed to 
remain the same at 50,000 cm-1 M-1. To calculate labelling efficiency equation 2 was used. 
 
Equation 2)   ܮܾ݈݈ܽ݁݅݊݃݂݂݁݅ܿ݅݁݊ܿݕ ൌ  ஺ఌೣ  ൈ  ெௐ௢௙௣௥௢௧௘௜௡௠௚௣௥௢௧௘௜௡Ȁ௠௅ ൌ  ௠௢௟௘௦௢௙ௗ௬௘௠௢௟௘௦௢௙௣௥௢௧௘௜௡ 
 
Where Ax ŝƐƚŚĞĂďƐŽƌďĂŶĐĞǀĂůƵĞŽĨƚŚĞĚǇĞĂƚƚŚĞĂďƐŽƌƉƚŝŽŶŵĂǆŝŵƵŵǁĂǀĞůĞŶŐƚŚ ?ɸŝƐƚŚĞŵŽůĂƌ
extinction coefficient of the dye at absorption maximum wavelength. SDS-PAGE analysis then showed 
the protein at the expected molecular weight of approximately 19,270 Da.  
2.10 Signal to noise fluorescence measurements of MDCC-SSB 
2µM MDCC-SSB subunits were serially diluted in 100µl of 50mM Tris.HCl pH 7.5, 3mM MgCl2 and 
100mM or 200mM NaCl as defined in a 96 well plate. For strength of signal to noise ratio a 
concentration of MDCC-SSB ranged from 0-0.25µM and both excitation and emission were measured 
from 400nm-440nm and 455nm-550nm respectively, using a ClarioStar microplate reader (BMG, 
LabTech, Ayelsbury, UK).  
2.11 Titrations of Oligonucleotides to MDCC-SSB 
 
1µM of ssDNA70/ssRNA70 was serial diluted across 10 wells of 100µl of 50nM MDCC-SSB in 50mM 
Tris.HCl pH 7.5, 3mM MgCl2 and 100mM or 200mM NaCl as defined. The fluorescence intensity was 
then taken at 471nm. Fluorescence change is presented as a ratio using equation 4.  
Equation 4)    ܨ݈ݑ݋ݎ݁ݏܿ݁݊ܿ݁݄ܿܽ݊݃݁ ൌ ி೔ൈ஽ி೔ிబ  
Where F0 is initial fluorescence intensity at 471nm and Fi is the intensity at 471nm after titration. DFi 





2.12 PcrA helicase assay with dsDNA 
 
20nM RepD was added to 5nM dsDNA in 50mM Tris.HCl pH 7.5, 100mM KCl and 10mM MgCl2 and 
incubated at 30ȗC for 15 minutes. 100nM of the helicase PcrA and 50nM of MDCC-SSB was then added 
and incubated at 30ȗC for 2 minutes. 1mM of ATP was then added to the mixture and 100µl of solution 
was placed in a well of a 96 well plate and incubated in the ClarioStar micƌŽƉůĂƚĞ ƌĞĂĚĞƌĂƚ  ? ?ȗ ?
Fluorescence emission taken at 470nm was measured every 30 seconds for 15 minutes.  
2.13 Competition assay 
 
50nM fluorescein ssDNA40 (fssDNA40), 50nM fssDNA40 with 75nM SSB and 75nM SSB with 1µM ssRNA70 
were set up respectively in individual wells in a 96 well plate. The fluorescence emission of all three 
ǁĞƌĞ ŵĞĂƐƵƌĞĚ ƵƐŝŶŐ ƚŚĞ ůĂƌŝŽƐƚĂƌ ŵŝĐƌŽƉůĂƚĞ ƌĞĂĚĞƌ ĨƌŽŵ  ? ? ?Ŷŵ ƚŽ  ? ? ?Ŷŵ Ăƚ  ? ?ȗ ?  ? ?ŶD ŽĨ
fluorescein ssDNA40 was then added to the solution containing 1µM ssRNA70 and the fluorescent 
intensities were re-measured using the same conditions. Fluorescence emission was then normalised 
to 1; 1 being the highest intensity of the free fluorescein ssDNA40. 
2.14 Post transcription analysis using SSB 
 
Post transcription was undertaken using the ,ŝ^ĐƌŝďĞ ?d ?,ŝŐŚzŝĞůĚZE^ǇŶƚŚĞƐŝƐ<ŝƚ (New England 
Biolabs, Hitchin, UK) and the template RecD2 gene which produces a transcript 2225nt long. The 
transcription was ran for various lengths of time to produce different amounts of transcript. RNA was 
then purified using RNeasy® kit (Qiagen, Manchester, UK). Once purified 1µl to of MDCC-SSB was 
added to 100µl of sample in a 96 well plate to make the final concentration 250nM. Alongside a control 
of MDCC-SSB alone, both the excitation and emission spectra were taken from 400nm-440nm and 
455nm-550nm respectively. RT-PCR was undertaken using the Qiagen QuantiFast SYBR Green RT-PCR 




2.15 Real time transcription analysis. 
 
Transcription was undertaken following the protocol and using the TranscriptAid T7 High Yield 
Transcription kit (Thermo scientific, Rochford, UK). The kits ? control DNA, which produces a 2222nt 
long transcript, was used as the template for the analysis and 250nM MDCC-SSB was added to the 
transcription mixture. 0.25µM MDCC-SSB in the transcription buffer, 0.25µM MDCC-SSB and 0.25µM 
MDCC-SSB with 1µM ssDNA70 both in 50mM Tris.HCl pH 7.5, 3mM MgCl2 and 100mM NaCl, were all 
set as controls. The transcription ƌĂŶĨŽƌ ?ŚŽƵƌƐĂƚ ? ?ȗŝŶƐŝĚĞƚŚĞůĂƌŝŽ^ƚĂƌmicroplate reader and 
emission at 470nm was measured in 1 minute intervals. A 1% agarose gel was used to analyse the 
products as instructed in the kits ? protocol.  
2.16 Circular Dichroism (CD) analysis. 
 
Structures of the unlabelled SSB, MDCC-SSB, MDCC-SSB bound with ssDNA70 and ssRNA70 were all 
analysed at 0.2mg.mL-1 in the far UV spectrum from 190nm-270nm using a Jasco J715 Circular 
Dichroism Spectrometer (Jasco Inc., Maryland, U.S.A). The proteins were incubated at 37°C and 
spectra were taken every 5 minutes for 3 hours. Following this incubation the samples were cooled 
down to  ? ?ȗ and then heated up ƚŽ ? ?ȗǁŝƚŚĂŵĞĂƐƵƌĞŵĞŶƚĂƚ ?10ŶŵďĞŝŶŐƚĂŬĞŶĂƚ ?ȗŝŶƚĞƌǀĂůƐ ?
4 readings were taken for each measurement and averaged by the software provided. For the 
conversion of elipticity to mean residue elipticity the following equation was used (equation 3).  
Equation 3)       ሾߠሿெோௐୀ ಾೈሺ೙షభሻൈఏ௟ൈ௖ൈଵ଴  
 
Where [ɽ]MRW is the mean residue elipticity, MW is the molecular weight of the protein, n is the 
number of amino acids, ɽ is the degrees in elipticity, l is the path length in cm and c is the concentration 
in g.L-1 Melting curves were established using Grafit (Erathicus, Horley, UK) and fitted with the 
sigmoidal Boltzman equation.  The cuvette was made from quartz and had a pathlength of 0.1cm. 
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2.17 Dynamic light scattering analysis (DLS) 
 
0.25µM of MDCC-SSB in 50mM Tris.HCl pH 7.5, 100mM NaCl, 3mM MgCl2 in a 50µl cuvette was placed 
in a Zetasizer Nano ZS DLS machine (Malvern Instruments, Malvern, UK) under the guidance of a 
ĐŽŵƉĂŶǇ ƌĞƉƌĞƐĞŶƚĂƚŝǀĞ ? ĨƚĞƌ  ? ŚŽƵƌƐ Ăƚ  ? ?ȗ ƚŚĞ ŵĞĂƐƵƌĞŵŶƚ ǁĂƐ ƌepeated. Analysis was 
undertaken using the Zetasizer software.  
2.18 Photostability of MDCC 
 
1µM of MDCC in 100µl of 50mM Tris.HCl pH 7.5, 100mM NaCl, 3mM MgCl2 in a 96 well plate was 

























3.1 Purification optimisation of G26c SSB. 
 
3.1.1 Polymin P and Ammonium sulfate precipitation 
 
The G26C SSB plasmid produced by Dilligham et al., did not contain any purification tag. Cells 
containing the G26C SSB plasmid provided by Dillingham et al were defrosted and sonicated for 5 
minutes overall. The protein purification protocol is from Dillingham et al49. Briefly for protein 
purification the samples underwent a Polymin P (0.4%) precipitation alongside an ammonium sulfate 
(150g l-1) precipitation. After final precipitation and centrifugation the pellet was resuspended in 50mL 
of 50mM Tri.HCl pH 8.3, 20% glycerol, 1mM EDTA and 0.2M NaCl. This resuspension was centrifuged 
Ăƚ ? ? ? ? ? ?ƌƉŵĨŽƌ ? ?ŵŝŶƵƚĞƐĂƚ ?ȗĂŶĚƚŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐĐŽůůĞĐƚĞĚĂŶĚŬĞƉƚĂƚ ?ȗ ? ?ŵ>,ĞƉĂƌŝŶ
column (GE healthcare, Little Chalfont, UK) was equilibrated in 50mM Tris.HCl pH 8.3, 20% glycerol, 
1mM EDTA and 50mM NaCl. The same buffer without NaCl was titrated into the supernatant to ensure 
the sample and column were at similar conductivities and the supernatant was loaded. The column 
was washed with the same equilibration buffer and eluted in a NaCl range of 50mM NaCl to 1M NaCl. 





















Figure 3.1. SDS-PAGE analysis of Polymin P and ammonium sulfate precipitation method. After both 
precipitations the sample was loaded onto a heparin column and eluted in 50mM Tris.HCl pH 8.3, 20% 
glycerol, 1mM EDTA and varied NaCl. No clear amount of protein in any elution fractions available for 
further use. 
3.1.2 Heparin Column with a Gel Filtration column.  
 
To ensure no loss of protein occurred the previous method was adapted. The same cells containing 
the same plasmid were defrosted and after cell sonication and centrifugation at 18,000rpm for 20 
ŵŝŶƵƚĞƐĂƚ ?ȗ ?ƚŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐĐŽůůĞĐƚĞĚĂŶĚůŽĂĚĞĚŽŶƚŽĂ ?ŵ>,ĞƉĂƌŝŶĐŽůƵŵŶ ?'ŚĞĂůƚŚĐĂƌĞ ?
Little Chalfont, UK) that had been equilibrated in 50mM Tris.HCl pH 8.3, 20% glycerol, 1mM EDTA and 
50mM NaCl. After washing once with the equilibration buffer the column was eluted using the same 
buffer with a NaCl range from 50mM to 1M NaCl. The sample was then analysed on SDS-PAGE (figure 
2.2a) Defined bands were shown at the molecular weight of single SSB subunits of approximately 
18,890kDa the theoretical mass of each SSB subunit. Samples containing SSB were then loaded onto 
a Superdex 200 10/300 GL gel filtration column (GE healthcare, Little Chalfont, UK) which was 
equilibrated in 50mM Tris.HCl pH 7.5, 1mM DTT, 150mM NaCl. The column was washed and eluted in 
this buffer. The samples were collected and analysed using SDS-PAGE (figure 2.2b). Whilst this method 
led to SSB elution the samples were deemed to be of too small amounts and too impure. 
25kDa 
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Figure 3.2. SDS-PAGE of heparin column and gel filtration column method. a) Presence of over 
expressed SSB after heparin column elution in 50mM Tris.HCl pH 8.3, 20% glycerol, 1mM EDTA. The 
two elution fractions were pooled together an loaded onto a gel filtration column in in 50mM Tris.HCl 
pH 7.5, 1mM DTT, 150mM NaCl. The elutions were analysed using SDS- PAGE (b) which showed 
presence of SSB in small impure quantities.  
 
3.1.3. Ammonium sulphate precipitation with a Q sepharose column. 
 
This method was adapted from Green et al63. Briefly, after cells containing the unlabelled SSB plasmid 
were defrosted, sonicated and centrifugedat 18,000rpm ĨŽƌ ? ?ŵŝŶƵƚĞƐĂƚ ?ȗ ?ƚŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐ
collected and 20% w/v ammonium sulphate was added and followed by a subsequent centrifugation 
at 18,000rpm at 4°C forced precipitation. The pellet was resuspended in 20mM Tris pH 7.5, 20mM 
NaCl and loaded onto a 5mL HiTrap Q column (GE healthcare, Litltle Chafont, UK). Elution occurred 
over 0-1M NaCl gradient. Those elutions were analysed using SDS-PAGE (figure 2.3a) and those 
containing protein were pooled and loaded onto a Superdex 200 10/300 GL gel filtration column (GE 
healthcare, Little Chalfont, UK) which was equilibrated in 50mM Tris.HCl pH 7.5, 1mM DTT, 150mM 
NaCl. The column was washed and eluted in this buffer. The samples were collected and analysed 
using SDS-PAGE (figure 2.3b).   















Figure 3.3. SDS-PAGE analysis of the adaptation of the Green et al63 SSB purification method. a) 3 
elutions from the Q sepharose column were analysed using SDS-PAGE, they show the presence of SSB 
with some contaminants. After pooling of the elutions they were loaded onto a gel filtration column. 
Three elutions fractions were collected and analysed using SDS-PAGE. Protein was present in all 
fractions however the analyses showed potential contaminants.  
3.1.4 His-tagged SSB 
 
E. coli cells containing the His-tagged SSB PET151 plasmid, were defrosted, sonicated for 5 minutes 
ĂŶĚĐĞŶƚƌŝĨƵŐĞĚĂƚ ? ? ? ? ? ?ƌƉŵĂƚ ?ȗ ?dŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐƚŚĞŶĐŽůůĞĐƚĞĚĂŶĚƐƚŽƌĞĚĂƚ ?ȗ ? ?ŵ>
His-Trap HP column (GE healthcare, Little Chalfont, UK) was equilibrated in 50mM Tris.HCl pH 7.5, 
40mM imidazole, 500mM NaCl and 1mM DTT. The supernatant was loaded onto the column and the 
column was washed with the equilibration buffer. The buffer was eluted using the same buffer with 
increasing imidazole concentrations from 40mM to 400mM. Samples were collected and analysed 


























Figure 3.4. An SDS-PAGE gel showing the presence of SSB. Targeted elution fractions from the His 
column that have the presence of SSB both in its monomer and dimer form in 50mM Tris.HCl pH 7.5, 
500mM NaCl and 1mM DTT and unknown imidazole concentration.   
3.2 Proving SSB does bind to mRNA. 
 
Fluorescent and non-fluorescent techniques show that SSB is a viable scaffold for an mRNA biosensor, 
as it binds to mRNA as previously shown61. Electrophoretic mobility shift assay (EMSA) shows that 
purified SSB is functional and is able to bind to ssRNA70 in a similar way to that of ssDNA at low NaCl 
concentrations (figure 3.1). Due to a lower concentration of protein compared to substrate it was not 











Figure 3.5. EMSA of SSB bound to both ssDNA70 and ssRNA70. 50nM of MDD-SSB was incubated with 
250nM ssDNA70 or ssRNA70 for 20 minutes at room temperature in a 100mM NaCl buffer and analysed 
using 12% acrylamide gel stained with SYBR®Gold. The unbound substrates progressed further 
through the gel to that of the bound. Both the bound ssDNA70 and ssRNA70 have similar splitting of 
bands.  
 
This EMSA showed similar binding properties for both substrates. To further confirm SSB does bind to 
ssRNA and to define the kinetic parameters, tryptophan fluorescence studies were used. Tryptophan 
reports on the intrinsic protein fluorescence. This type of fluorescence reflects the local environment 
the tryptophan residues are found in, and so when binding occurs, these microenvironments change 
due to SSB changing its conformation. In SSB four tryptophan residues can be found at positions; 41, 
55, 89 and 136. It has been shown that the tryptophan at position 54 is involved directly in the binding 
of ssDNA64. Tryptophan fluorescence was measured in two salt concentrations using two different 
methods. At 100mM NaCl, tryptophan fluorescence was measured using a fluorescence 
spectrophotometer. Previously Lohman et al65  have observed 80% fluorescence quenching when SSB 
Bound states of SSB  
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was bound to ssDNA at a higher salt concentration66. The second method employed to measure 
tryptophan fluorescence at a high salt concentration was to use thermophoresis, where serial dilutions 
within small capillaries were set up to measure the intrinsic fluorescence measured with a label free 
NanoTemper machine (NanoTemper technologies, Munich, Germany).  
As shown in figure 3.2 at 100mM NaCl, saturation of the tryptophan quenching when using 50nM SSB 
occurs at 25nM ssDNA70. The results were fitted using two linear regressions to identify a point in 
which tryptophan quenching reaches a maximum and an increase of substrate does not cause further 
tryptophan quenching. This tight binding of ssDNA70 result implies that at low salt, there is one SSB 
tetramer binding to two molecules of ssDNA70. When SSB binds to increasing concentrations of the 
RNA substrate, ssRNA70, saturation of the tryptophan quenching occurs slightly higher at 34nM. This 
implies there is at least a 1:1 binding ratio of SSB to ssRNA70 molecules but potentially there could be 
two. However the data quality is not ideal with multiple outliers, and so to make an accurate 
judgement further work is required. Whilst it is difficult to predict the SSB species this study has shown 
that binding to both substrates behaves in a similar manner at low salt concentrations. One factor that 
needs to be taken into consideration is that DNA substrates are also able to emit some fluorescence 
at 325nm and so can provide background fluorescence which limits signal quenching and so 100% 






Figure 3.6. Tryptophan quenching shows similar binding of ssDNA70 and ssRNA70 substrates to SSB. 
In 100mM NaCl buffer, 50nM SSB was titrated with ssDNA70 (a) or ssRNA70 (b) and the intrinsic 
tryptophan fluorescence quenching was measured at 325nm. The intensities were corrected for 
dilution and quenching saturation was measured to occur at 25nM and 34nM respectively. This was 
calculated from the interception of the two linear regression fits and both results show a stoichiometry 
of 1:1. Outliers of the linear regressions are highlighted in red.  
 
A second method to study binding was to use thermophoresis. Microscale thermophoresis uses 
infrared light to slightly increase the temperature of a specific area67. Tryptophan fluorescence is 
measured after irradiation to quantify changes in the mobility of the protein, since protein bound to 
substrate would have a reduced mobility compared to its free form. ssDNA70 and ssRNA70 titrations 
were completed at a higher salt concentration in PBS buffer to further characterise mRNA binding. 
Using intrinsic tryptophan fluorescence, the Label Free NanoTemper was used to observe tryptophan 
fluorescence across a serial dilution of ssDNA70 and ssRNA70 substrates. Concentrations of ssDNA70 and 
ssRNA70 (0-1µM) were titrated against 50nM of SSB and the tryptophan quenching was calculated with 
the software provided. The observed apparent Kd ?Ɛare 50nM and 164nM respectively. This shows that 
at a higher salt concentration the binding stoichiometry of SSB to ssDNA70 is once again 1:1, but due 




subunits binding in a dimeric form to the ssRNA70. Therefore a stoichiometry of [SSBmonomers]2: 1 
ssRNA70 is observed. The results were plotted as shown in figure 3.3 and provided by NanoTemper 
(Munich, Germany). This result shows a difference in binding strength ďƵƚƐƚŝůůĐŽŶĨŝƌŵƐ^^ ?ƐĂďŝůŝƚǇ











Figure 3.7. ^^ ?Ɛ Intrinsic Tryptophan fluorescence movement measured by the label free 
NanoTemper. 50nM of SSB in 1x PBS buffer was kept constant whilst (a) ssDNA70 or (b) ssRNA70 
concentrations varied between 10µM- 30pM. The assay was performed in PBS with 0.05% TWEEN-20. 
After short incubation samples were loaded into MST NT.Labelfree standard glass capillaries and the 
tryptophan fluorescence was analysed. Concentrations on the x-axis are plotted in nM. For ssDNA70 






A fluorescent method reinforces that SSB binding to mRNA does occur. SSB was titrated against 
fluorescein (f) labelled nucleotides, fssDNA16 and fpolyU20 (figure 3.4). Upon addition of SSB to these 
fluorescent substrates, quenching of the fluorescent signal is observed. Whilst fluorescent quenching 
occurred, there was no clear concentration dependent binding curves for either substrates. The 
amount of fluorescence quenched decreased over SSB concentration for ssDNA16 but when titrating 
into polyU20 a binding curve is not apparent. There also seems to be clear outliers at 1µM SSB for both 
fluorescent nucleotide substrates. These final SSB binding results support the previous data shown 
and corroborates the previous statement that SSB does bind to ssRNA70.  
 
Figure 3.8. Quenching of fluorescein nucleotides due to SSB titrations. 1µM SSB was titrated into 
1µM of fssDNA16 (a,b) and 1µM of fpolyU20 (c,d) in 100mM NaCl buffer. Complete emission scans were 
taken from 520nm to 600nm with and without 1µM SSB and normalised to 1 (a,c). Fluorescence 























To confirm the weaker binding of SSB to ssRNA compared to ssDNA, as observed in previous results, a 
competition assay was set up using fluorescein labelled ssDNA40 (fssDNA40) (figure 3.5). In this assay, 
alongside two controls of bound SSB-fssDNA40 and free fssDNA40, SSB was pre-incubated with 1µM of 
ssRNA70 and the emission spectra were taken from 520-600nm. fssDNA40 was added and the spectra 
were retaken. These spectra matched that of the SSB bound to fssDNA40 and not the free fssDNA40 
which implies the ssRNA has been outcompeted by the fssDNA40. This shows that SSB has weaker 
binding to ssRNA and potentially has preferred affinity to ssDNA. This could be explained by non-
specific interactions between the protein and the fluorophore. Moreover due to the two different 
binding modes of SSB it could be possible that both fssDNA40 and ssRNA70 are bound in tandem with 
two OB-folds binding to each substrate. To improve the competition assay fssDNA70 substrates should 








Figure 3.9. fssDNA40 outcompetes ssRNA70 for SSB binding. 75nM SSB was incubated with 1µM 
ssRNA70 along with two controls, 50nM fluorescein ssDNA40 (fssDNA40) and 50nM fssDNA40 with 75nM 
SSB. After emission spectra (520-600nm) were taken, 50nM of fssDNA40 was added to the SSB, ssRNA70 
mixture and the emission was re-measured. All spectra were normalised to 1.The fluorescence spectra 
show the same fluorescence as the SSB with fssDNA40 solution showing binding of fssDNA40 has 
occurred and the ssRNA70 has been displaced. 
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3.3 The design of the MDCC-SSB biosensor.   
 
The point mutation of glycine to cysteine at position 26 provides the only cysteine residue within the 
protein, which limits the side effects of fluorescent labelling such as over labelling. SSB labelling 
optimisation was able to be carried out due to this single cysteine residue, ensuring the highest 
amount of SSB monomers were labelled with MDCC. Incubation lengths and temperatures were as 
shown in table 1. Four hours incubation with MDCC at room temperature is the optimum labelling 
condition. In its tetrameric formation this leads to 3 out of 4 subunits to be fluorescently labelled. 
tŚŝůƐƚ ƐŝŵŝůĂƌ ůĂďĞůůŝŶŐ ŝƐ ŽďƐĞƌǀĞĚ ŽǀĞƌ ŶŝŐŚƚ Ăƚ  ?ȗ ? ƚŽ ŵĂŬĞ ůĂďĞůůŝŶŐ ƋƵŝĐŬ ĂŶĚ ĞĂƐǇ ŝƚ ŝƐ
recommended to incubate SSB with MDCC for a minimum of 4 hours. Appropriate molecular weights 
were observed for both MDCC-SSB and unlabelled SSB using SDS-PAGE analysis (figure 3.6).  
 
Table 1. Table to show optimisation of MDCC labelling of SSB. Optimised labelling occurs after 4 hours 
at room temperature. Incubation times varied from 2 hours to overnight. The concentrations of SSB 
monomers were measured at 280nm with extinction coefficient of 25,000 cm-1 M-1 and MDCC 
concentrations were measured at 435nm with extinction coefficient of 50,000 cm-1 M-1. A ratio of the 
concentrations was taken. 
 
 
Length of Time 
Concentration of SSB 
monomers (µM) 
Concentration of MDCC 
(µM)  
Amount of monomers labelled 
in a tetramer. 
2 Hours  1µM  0.4µM  ~1/2 
4 Hours   16.6µM  13.2µM ~3/4 












Figure 3.10. SDS-PAGE gel showing labelling of SSB with MDCC-SSB. Both samples of SSB (A) and 
MDCC-SSB (B) were analysed using SDS-PAGE. (A) Showed a large band at approximately 18.9kDa and 
37.8kDa which are SSB subunits as monomers and dimers. (B) shows a band at 19.27kDa which is 
MDCC labelled SSB monomers due to DTT treatment and a slight band at approximately 37kDa 
showing unlabelled dimers remaining after the DTT treatment.  
 
A sufficient signal was ensured by measuring the fluorescence intensity using a serial dilution of SSB 
subunits from 1µM-0.0625µM (figure 3.7). The fluorescence signal is MDCC-SSB concentration 
dependent and occurs in a linear fashion at both 100mM NaCl and 200mM NaCl concentrations. This 
shows that there are no artificial signals from the wells used in the plate reader and the protein and 
signal are stable over varying concentrations. 200nM subunits, 50nM SSB tetramer was deemed a 
suitable concentration to produce a reliable signal for further studies- the biosensor had the potential 
at higher concentrations to form oligomers which would affect the signal, or at lower concentrations 










signal. However, this was seen to not be the case. When MDCC is bound to SSB its excitation peak 
occurs at 435nm and the emission peak is at 470nm, giving a Stokes shift of 35nm.     
 
Figure 3.11. Fluorescence increases in a linear fashion with increasing MDCC-SSB subunits at both 
high and low salt conditions. MDCC-SSB was serial diluted from 1µM to 0.0625µM and was made up 
to 100µl in 100mM (a) or 200mM (b) NaCl buffer in a 96 well plate. Excitation spectra were taken from 
400-440nm and emission fluorescence taken from 455-550nm. Excitation peak occurred at 435nm 
and emission peak at 470nm with a Stokes shift of 35nm. 3 spectra were averaged and plotted with 
standard error for each concentration. Emission measured at 470nM was normalised to 1 and plotted 
against MDCC-SSB subunit concentration in 100mM NaCl buffer (c) and 200mM NaCl buffer (d) with 
standard deviation, showing a linear increase with a signal being stable at high and low salt 
concentrations. 





































The biosensor responds to the addition of ssRNA and ssDNA substrates. A 1.9 fold increase is observed 
when 1µM of ssDNA70 is added to 50nM MDCC-SSB tetramers and a 2.1 fold increase is observed with 
addition of 1µM ssRNA70 to 50nM MDCC-SSB tetramers (figure 3.8). This corroborates with previous 
studies49,63 that a fluorescence increase is observed when SSB with a coumarin dye attached binds to 
ssDNA70. It also shows MDCC-SSB is a suitable biosensor for ssRNA detection. The stokes shift for both 









Figure 3.12. Excitation and emission scan of MDCC-SSB with and without substrates. 50nM MDCC-
SSB tetramers were incubated with 1µM of ssDNA70 or 1µM ssRNA70 in 100mM NaCl buffer. Compared 
to MDCC-SSB alone there was a 1.9 fold increase in fluorescence when bound to ssDNA70 and 2.1 fold 
increase when bound to ssRNA70. Excitation spectra was taken from 400-440nm and emission was 
taken from 455-550nm.  
3.4 Testing the biosensor  
 
As shown previously by Dillingham et al., 49 the MDCC-SSB can be used to measure helicase activity. 
To ensure the biosensor designed here behaves in a similar way, the helicase PcrA activity was 






loading factor, RepD. Once incubation was complete, helicase activity was initiated with the addition 
of PcrA and ATP. Following a lag phase which is typical for PcrA68 ,a fluorescence increase was observed 
over 2.5 minutes in real time as the dsDNA is unwound and MDCC-SSB binds to the available ssDNA. 
The signal then reached a plateau as the unwinding was complete (figure 3.9). With the concentration 
of DNA being 1000 base pairs long there are 15 potential binding sites for (SSB)65. This means the 
concentration of binding sites of 5nM DNA substrate is 75nM. The peak fluorescence increase shown 
in this study has seen to be 1.9 fold for ssDNA when saturating the biosensor. In this assay though 
there was only a fluorescent increase 10% of this figure. This suggests that dsDNA was not completely 
unwound, as saturation of the sensor should have occurred at 50nM of biosensor. Incomplete 
unwinding could be due to damaged RepD within the sample, as helicase activity will not occur without 










Figure 3.13. Fluorescence increase as MDCC-SSB binds ssDNA produced by the helicase PcrA.  5nM 
1kbp dsDNA was incubated with 20nM RepD and 50nM MDCC-SSB tetramers at 30°C for 15 minutes. 
After incubation 100nM PcrA and 1mM ATP was added initiating the reaction which was allowed to 
proceed for 15 minutes at 30°C in 100µl in a 96 well plate in a micro plate reader. Fluorescence was 
measured at 470nm.  
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3.5 Characterisation of the MDCC-SSB biosensor  
 
All quoted concentrations for MDCC-SSB within this section refer to the concentration of MDCC-SSB 
tetramers unless stated otherwise. MDCC-SSB fluorescence increase is dependent on the 
concentration of ssDNA70. Until a saturation point, there is a linear increase in fluorescence that can 
be used to calibrate the biosensor.  SSB is a tight binding protein, as a result, the interaction with 
ssDNA has a small Kd (within the low pM to low nM range)69, therefore any free ssDNA should be 
bound by the biosensor. This, however, means that when using lower MDCC-SSB concentrations the 
DNA may not be detected before the Kd is approached. This tight binding theoretically means that a 
fluorescence signal should increase linearly up to the MDCC-SSB concentration used. Once this has 
been reached, a plateau should occur depending on the SSB species within the sample. This has been 
explained in figure 3.10. 
When titrating ssDNA70 into MDCC-SSB solution there is a clear linear phase in both 100mM NaCl and 
200mM NaCl buffers however the saturation points observed are not identical (figure 3.11). At 100mM 
NaCl, saturation of the sensor occurred at 64.3nM which means at a concentration of 50nM, MDCC-
SSB is able to distinguish between ssDNA70 concentrations of 3.9nM, the lowest titre, to 104.4nM. At 
200mM NaCl saturation of the sensor occurs earlier at 90.3nM, which is only a slight reduction in 
sensitivity of MDCC-SSB. The later saturations are most likely due to a mixture of labelled tetramers 
and dimers as well as unlabelled species. During the titrations there are some strong outliers that do 
not fit the linear regressions, therefore, care has to be taken when using this sensor as the results may 














Figure 3.14. Potential binding modes of 50nM MDCC-SSB with the titration of ssDNA70 substrates, 
showing a variation in fluorescence saturation. Due to the low Kd of SSB it is expected that binding 
occurs rapidly within the MDCC-SSB system. From this, it is assumed that if 50nM MDCC-SSB is used, 
at the point of signal saturation all MDCC-SSB proteins are bound to substrate. Therefore if a 
saturation point occurs at 25nM ssDNA70 (a) then all MDCC-SSB tetramers are bound to two substrates 
each. If saturation occurs at 50nM ssDNA70 (b) then a 1:1 stochiometry occurs in which there is one 
ssDNA70 to one SSB tetramer. If a saturation is observed at  100nM ssDNA70 then there could be two 
potential binding modes of SSB in which two tetramers bind along the ssDNA70 in a (SSB)35 binding 
mode or two dimers bind along the ssDNA70 in a similar manner (c).  
 
MDCC-SSB fluorescence increase also occurs with an increase in ssRNA70 concentration, similar to that 
shown with ssDNA70. A linear phase occurs at both high and low salt and the saturation point for 
ssRNA70 occurs later compared to that seen with ssDNA70 (figure 3.12). At low salt concentrations a 
saturation point occurred at 101nM of ssRNA70 and at the higher salt concentration a saturation point 
occurs at 109nM, as shown in figure 3.3.3. This shows the biosensor has an increased sensitivity to 
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ssRNA70 compared to ssDNA70 in both salt concentrations as it is able to distinguish concentrations 
from the 3.9nM titre to 109nM ssRNA .  
 
Figure 3.15. Titrations of ssDNA70 with 50nM MDCC-SSB showing a linear phase and a saturation 
phase. ssDNA70 was serially diluted against 50nM of MDCC-SSB and the fluorescence emission was 
measured at 470nm in a 96 well plate. The increase was normalised to MDCC-SSB alone and corrected 
for dilutions, then plotted with standard error. The titrations were done in 100mM NaCl buffer (a) 
where a saturation was seen at 64.3nM of ssDNA70 or 200mM NaCl buffer (b) where a saturation of 
sensor was seen at 90.3nM ssDNA70. Both titrations showed a linear phase but saturated at a later 












Figure 3.16. Titrations of ssRNA70 with 50nM MDCC-SSB showing a two phase system. ssRNA70 was 
serially diluted against 50nM of MDCC-SSB and the fluorescence emission was measured at 470nm in 
a 96 well plate. The increase was corrected for dilution and normalised to MDCC-SSB alone, then 
plotted with standard error. The titrations were done in 100mM NaCl buffer (a) with saturation 
observed at 101nM of ssRNA70 or 200mM NaCl buffer (b) where saturation of the sensor was observed 
at 109nM ssRNA70. At both high and low salt concentrations, a linear phase was observed.  
 
3.6 Application of MDCC-SSB biosensor to measure in vitro transcripts.  
 
The biosensor has shown its ability to bind to ssRNA and the fluorescence signal corresponds to 
concentrations of ssRNA present. To test the capability of the biosensor to detect concentrations of 
mRNA samples of different lengths other than the 70 nucleotide long samples previously used, an in 
vitro transcription assay was set up. The template DNA was the gene RecD2 with a T7 promotor which 
results in a 2225 nt run off. The transcription assays were set to run for varying amounts of time 
resulting in different mRNA concentrations. Once the mRNA was purified, it was quantified using RT-
qPCR. Quantification was performed against a series of known amounts of template. The amount of 




abortive transcriptions that will not be able to bind to the PCR primers.  1µM of MDCC-SSB was added 
to each sample of purified mRNA and the excitation and emission spectra were taken and compared 
to the RT-qPCR results. MDCC-SSB can be used qualitatively to compare mRNA transcripts present and 
there is a linear increase in fluorescence compared to amount of mRNA transcript (ng) (figure 3.13). 








Figure 3.17. MDCC-SSB biosensor can be used to compare transcription samples. 1µM was added to 
pure mRNA transcripts produced by the T7 polymerase transcribing a 2225nt transcript for various 
lengths of time resulting in different amounts (ng) of mRNA. The excitation (400-445nm) and emission 
(450-550nm) spectra were taken of each sample with MDCC-SSB alone as the control (a). RT-qPCR of 
the samples were performed against known amounts of template and the amounts of mRNA 
transcribed were calculated from this. Peak emission of the MDCC-SSB at 470nm was then plotted 
against the amount of mRNA transcript calculated using RT-qPCR (b). There is a clear linear increase 
in fluorescence, which is dependent on the amount of mRNA transcribed. The MDCC-SSB fluorescence 
reflected the difference in mRNA concentrations.  
The qualitative study showed that MDCC-SSB does respond to the different concentrations of 
nucleotides. However, with the lowest amount of mRNA transcribed being 35ng and the next being 
215ng there is some overlap in the low concentration MDCC-SSB fluorescence spectra (figure 3.13a). 




This result could be due to contaminated samples containing ssDNA or errors the calculated mRNA 
amounts. The final assay was to undertake a T7 polymerase, transcription whilst MDCC-SSB is present 
in the solution, and to observe the transcription of mRNA in real time by measuring the fluorescence 
emission of the MDCC-SSB.  
MDCC-SSB is not a suitable biosensor for the real time measurement of transcription due to a loss of 
fluorescence over time (figure 3.14). In this assay the T7 polymerase kit was used to transcribe a DNA 
template of 2223nt with 250nM of MDCC-SSB incorporated into the assay. A few controls were set 
up, including MDCC-SSB in the transcription buffer only; MDCC-SSB in the 100mM NaCl buffer, as 
previously used, and MDCC-SSB with ssDNA70 in the 100mM NaCl buffer. This allowed any changes of 
fluorescence over time in the transcription buffer to be solely down to the transcription of mRNA. As 
the assay ran, a decrease in fluorescence occurred in all controls and the transcription assay. The 
decrease in fluorescence occurred more dramatically in samples that contained either mRNA or 
ssDNA70, with the MDCC-SSB alone in 100mM NaCl buffer losing the least amount of fluorescence. The 
decrease occurred in a clear rapid phase over ten minutes and then decreased at a steady rate for the 
remainder of the assay.  
 To ensure mRNA was being transcribed by the T7 polymerase and the biosensor was not responding, 
gel electrophoresis was used to show the presence of mRNA. The transcription sample was ran on a 









Figure 3.18. MDCC-SSB is not a suitable biosensor for the real time analysis of transcription. 250nM 
MDCC-SSB was added to the polymerase mix as stated in the TranscriptAid T7 High Yield Transcription 
kit, controls were also set up, 250nM MDCC-SSB alone in transcription buffer provided in the kit, 
250nM alone in 100mM NaCl buffer as previously used and 250nM with 1µM ssDNA70 in 100mM NaCl 
buffer. The transcription proceeded ĨŽƌ ?ŚŽƵƌƐĂƚ ? ?ȗŝŶǁŚŝĐŚĂ ? ? ? ?ŶƚůŽŶŐŐĞŶĞǁĂƐƚƌĂŶƐĐƌŝďĞĚ
and the MDCC-SSB emission was measured at 470nm every minute. Decrease in fluorescence occurred 
in all samples in a similar fashion with a rapid decrease in the first 10 minutes and a steady decrease 
for the remaining period of time. All samples were normalised to 1, which is the original fluorescence 
of MDCC-SSB in the designated buffer. 
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Figure 3.19. An acrylamide gel to show the presence of mRNA from the T7 polymerase assay with 
MDCC-SSB. A 100 times diluted sample taken from the MDCC-SSB transcription mix was loaded onto 
a 1% agarose gel in a 1X MOPS buffer and stained with SYBR Gold (no ladder was used due to the 
ladder provided containing Ethidium Bromide). One band was observed, suggesting the presence of 
mRNA transcripts.  
 
3.7 Evaluating the loss of fluorescence 
 
To understand the loss of fluorescence during the 3 hoƵƌƚƌĂŶƐĐƌŝƉƚŝŽŶƉĞƌŝŽĚĂƚ ? ?ȗ ?ǀĂƌŝŽƵƐŵĞƚŚŽĚƐ
were used. Firstly, the coumarin dye MDCC does not lose any fluorescence over the 3 hours due to 
bleaching effects or fluorescence lifetime effects in 100mM NaCl buffer (figure 3.16).  










Figure 3.20. DĚŽĞƐŶŽƚůŽƐĞĨůƵŽƌĞƐĐĞŶĐĞŽǀĞƌ ?ŚŽƵƌƐĂƚ ? ?ȗ ?1µM of MDCC in 100mM NaCl 
ďƵĨĨĞƌǁĂƐŝŶĐƵďĂƚĞĚĂƚ ? ?ȗĨŽƌ ?ŚŽƵƌƐ ?dŚĞĞŵŝƐƐŝŽŶǁĂƐŵĞĂƐƵƌĞĚĂƚ ? ? ?ŶŵĂŶĚreadings were 
taken every 5 minutes and plotted with standard error. Over three hours there is not a reduction in 
fluorescence but a gradual increase in MDCC fluorescence is observed.  
 
Whilst there is not a decrease in fluorescence there does seem to be a slight increase over time to 
ĂƉƉƌŽǆŝŵĂƚĞůǇ Ă  ? ? ? ĨŽůĚ ŝŶĐƌĞĂƐĞ ? D ?Ɛ ůŝĨĞ ƚŝŵĞ Žƌ ďůĞĂĐŚŝŶŐ ĞĨĨĞĐƚƐ ĐĂƵƐĞĚ ďǇ ĐŽŶƚŝŶƵŽƵƐ 
excitement can be ruled out for the loss of fluorescence.  
MDCC-SSB exhibits nŽůŽƐƐŽĨƐƚƌƵĐƚƵƌĞŽǀĞƌ ?ŚŽƵƌ ?Ɛ ŝŶĐƵďĂƚŝŽŶĂƚ ? ?ȗ ?To understand if the decrease 
in fluorescence was due to unfolding of the MDCC-SSB, as a result of labelling or instability in 100mM 
NaCl buffer, circular dichroism (CD) spectra were taken of SSB and MDCC-SSB (figure 3.17). After three 


























Figure 3.21. CD spectra showing no severe loss of structure of any SSB species over 3 hours. 
0.2mg.mL-1 of SSB (a), MDCC-^^  ?ď ?ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ĨŽƌ  ?ŚŽƵƌƐĂƚ  ? ?ȗĂŶĚŵĞĂƐƵƌĞŵĞŶƚƐǁĞƌĞ
taken in the far UV wavelengths (200-270) every 60 minutes.  
 
After 3 hours of incubation CD was used to calculate the melting points of each SSB species (figure 
3.18). The melting points showed no loss of stability, ƉƌŽƚĞŝŶŚĂǀŝŶŐĂŵĞůƚŝŶŐƉŽŝŶƚŽĨ ? ? ? ? ?A? ? ? ? ?ȗ
and MDCC-SSB having a ŵĞůƚŝŶŐ ƉŽŝŶƚ ŽĨ  ? ? ? ? ?A?  ? ? ? ?ȗ ?The bound MDCC-SSB with ssDNA70 and 
ssRNA70 had higher melting points, suggesting that SSB/MDCC-SSB is more stable in its bound form, at 
 ? ? ? ? ?A? ? ? ? ?ȗĂŶĚ ? ? ? ? ?A? ? ? ? ?ȗƌĞƐƉĞĐƚŝǀĞůǇ ?dŚĞƐĞŚŝŐŚŵĞůƚŝŶŐƉŽŝŶƚƐsupport the idea that there is 
no loss of protein structure during the 3 hour incubation period. 
Since the decrease in fluorescence is not caused by MDCC, or a loss of protein structure, dynamic light 
scattering analysis (DLS) was used to measure the proteins size before and after a 3 hour incubation 
Ăƚ ? ?ȗ, to specifically look for protein aggregation (figure 3.19). The DLS data shows that the majority 
of the MDCC-SSB species diameter after 3 hours has increased from 14.8nm to 1.19µm, which shows 
that aggregation has occurred. This aggregation is the most plausible cause for the decrease in 
fluorescence.   
b) 
a) 
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Figure 3.22. Melting curves of SSB species. 0.2mg.mL-1 of SSB (a) and MDCC-SSB (b) after three hours 
of incubation were heated by  ?ȗĨŽƌĞǀĞƌǇŵŝŶƵƚĞ ? ?ƌĞĂĚŝŶŐƐtaken at 210nm were taken for each 
temperature and averaged together. The same was done for MDCC-SSB bound to 0.2mg.mL-1 of 
ssDNA70 (c) and 0.2mg.mL-1 of ssRNA70 (d). The curves were fit with a sigmoidal Boltzmann fit, and gave 
ƚŚĞ ŵĞůƚŝŶŐ ƉŽŝŶƚƐ ? ^^A? ? ? ? ? ?A? ? ? ? ?ȗ ? D-^^A? ? ? ? ? ?A?  ? ? ? ?ȗ ? D-SSB with 
ssDNA70A? ? ? ? ? ?A? ? ? ? ?ȗĂŶĚD-SSB with ssRNA70A? ? ? ? ? ?A? ? ? ? ?ȗC.  
Temperature (°C )









































































































































Figure 3.23. Dynamic Light Scattering (DLS) diameter measurements of MDCC before and after a 3 
ŚŽƵƌŝŶĐƵďĂƚŝŽŶĂƚ ? ?ȗ ?250nM of MDCC-SSB in 100mM NaCl buffer was placed in the DLS machine 
and diameter measurements were taken. The sample was incubateĚ Ăƚ  ? ?ȗ ĨŽƌ  ? ŚŽƵƌƐ ĂŶĚ ƚŚĞ
measurement was repeated. There is a clear increase in diameters measured from 14.8nm to 1.19µm 
























0  H o u rs





Biosensors create unique opportunities to measure previously unmeasurable cell activities both in 
vitro and in vivo. They have provided opportunities for detecting toxins70, quantifying glucose in cells 
to aid with diabetes71 and measuring enzyme kinetics72. This ability to manipulate biological structures 
and specificity is an idea that has been key to this study.   
4.1 SSB can bind RNA substrates  
 
The optimisation process of SSB purification allows the process of making this biosensor cheap and 
easy to reproduce. This study removed the unnecessary steps of using Polymin P precipitation and 
ammonium sulfate precipitation which was shown to lead to expressed protein being lost. Instead a 
poly-histidine tagged protein reduced the purification to a one column process resulting in the high 
yield of a near pure product. This process of optimisation has reduced the time needed to produce 
the biosensor and, therefore encourages further use in different studies.  
During the production of this biosensor it was vital to compare the SSB binding to ssRNA with ssDNA. 
This is because SSBs role has been well characterised in binding to ssDNA54 and so any observed results 
of MDCC-SSB ssDNA binding would act as a positive control throughout the production of the 
biosensor. This study has reinforced the idea that SSB is able to bind to multiple substrates, but favours 
ssDNA over ssRNA. The first studies on unlabelled SSB using EMSA, substrate titrations and 
thermophoresis support the idea that SSB is able to bind to both ssDNA and ssRNA. RNA binding has 
already been previously shown by Shimamoto et al61, within the context of ^^ ?Ɛability to bind to its 
own mRNA. Whilst this has been reported it was important to reinforce this knowledge and compare 
the binding of both substrates that were designed to be of same lengths.  As SSB binding occurs 
through its OB-folds, it is assumed that mRNA binding would occur, as this type of interaction does 
not distinguish between ssDNA and ssRNA substrates73. The EMSA showed binding of both substrates 
and a splitting of bands due to the different SSB species binding to those substrates. However, as the 
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substrates were in excess not the protein, there was still some ssDNA and ssRNA that travelled freely 
through the gel.  
The tryptophan quenching studies using the fluorescence spectrophotometer showed that binding 
occurs for both substrates, although tryptophan quenching was observed it was much lower than the 
expected 80% quenching. This could be due to the low salt concentration used compared to previous 
studies and the potential of background nucleotide fluorescence. Complete saturation did not occur 
with quenching entering a second reduced gradient linear phase. This could be because of slight 
conformational changes SSB undertakes over time and gentle rearrangements of the substrate within 
the protein and so the quoted value of percentages is not calculated knowing the 100% quenched 
value.  
The use of thermophoresis gave a more accurate depiction of both the binding modes of SSB when 
binding to the two substrates. This is due to the ability of ssDNA to fluoresce within the protein-UV 
spectra, which can cause background fluorescence when using a simple fluorescence 
spectrophotometer. As thermophoresis uses a small pathlength, small quantities of SSB and is a 
relatively rapid procedure, there is a reduction in the error caused by internal filtering effects and 
bleaching effects of the tryptophan fluorescence.  The observation that binding stoichiometry is 
different for the ssDNA and ssRNA substrates arose from the apparent Kd ?Ɛ being 50nM and 134nM 
for ssDNA and ssRNA respectively. A 1:1 of complete SSB homotetramer to one molecule of ssDNA70 
stochiometry is defined but for ssRNA a ratio of 2 SSB subunits seems to bind to 1 molecule of ssRNA70. 
This ratio of binding implies that there are more SSB species in the (SSB)35  binding mode at 150mM 
NaCl when with the ssRNA70 compared to the (SSB)65 binding mode with ssDNA70 at this salt 
concentration. These differences in apparent Kds could be explained by two ssRNA70 molecules binding 
to one SSB tetramer or that SSB is in a dimer formation when interacting with ssRNA70 at this salt 
concentration. These binding modes need to be considered when discussing the saturation of SSB 
molecules with substrate as an array of SSB monomer conformations could be occurring due to the 
buffer or substrate composition.  
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Concentration dependent binding curves do not occur when using fluorescent oligonucleotides, 
potentially due to the short length employed in these studies. Nevertheless, this technique was 
utilised to show that ĞǀĞŶĂŶ “extreme ? example of mRNA transcript- a transcript that contains only 
uracil nucleotides- can be bound by SSB. The fPolyU20, a fluorescein tagged twenty uracil nucleotide 
RNA molecule is quenched when SSB is added to the sample. This quenching however for both the 
fssDNA16 and the fPolyU20 does not produce a distinctive binding curve when SSB is titrated into the 
system. The fssDNA16 substrate showed a decrease in percentage of fluorescence quenched with an 
increase of SSB concentration, but for the fpolyU20 substrate a trend is far harder to see. The 
explanation could be related to the length of the nucleotide strands. It is hard to predict where exactly 
the OB-fold will be able to bind on the nucleotides and exactly how many OB-folds will interact with 
these particularly short nucleotide sequences, which could lead to heterogeneous quenching of the 
signal within the SSB sample and explains why a binding curve is not easily observed. This is 
summarised in figure 4.1.  
 
Figure 4.1. Diagram showing potential binding conformations of short fluorescent nucleotides to 
SSB. fssDNA16 molecules bound to SSB with a) SSB binding the centre of the substrate. b) two 
monomers binding the molecule with increased quenching of the fluorescein due to proximity of 
protein. c) fssDNA16 bound to one monomer of SSB near the fluorescein binding site causing high 
quenching and d) binding of the molecule to one SSB monomer at the opposite end of the fluorescein 
dye allowing free rotation of the fluorescein with normal fluorescence intensity.  
 
d) a) b) c) 
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Binding kinetics may have an effect on the biosensors reliability when measuring mRNA 
concentrations in a sample containing ssDNA. The competition assay showed the biosensor is not 
suitable to be used when a solution contains ssDNA because the fssDNA40 was able to outcompete the 
ssRNA70 for binding to the SSB. To improve this assay and to ensure all bound ssRNA can be displaced 
by ssDNA, it would be necessary to increase the length of the fluorescein ssDNA to match the length 
of the RNA used. This would prevent the SSB tetramer from binding both substrates at the same time, 
as SSB could be in various binding modes for substrates 40 nucleotides long. The competition assay 
between ssRNA70 and fssDNA40 reinforces the importance of a sample to not contain ssDNA. 
4.2 Generating the biosensor  
 
Labelling optimisation has led to at least three out of the four SSB monomers, each containing a single 
cysteine residue, to be labelled.  Optimisation of labelling methods became the next priority after 
confirmation of mRNA binding to ensure a large enough amount of SSB subunits are labelled with 
MDCC to produce a viable signal. The labelling technique varied from previous protocols49,63 in which 
labelling occurred under nitrogen gas. The nitrogen in these methods act as an oxidising agent and 
stops the cysteine residues from forming dimers whilst labelling occurs. Although this method would 
ensure a higher percentage of monomer labelling, to ease the production of the MDCC-SSB biosensor 
it was not deemed unnecessary, as sufficient labelling occurs without it. To increase labelling efficiency 
of cysteine residues with MDCC, the optimisation process would need to be revisited to include 
nitrogen or the use of ɴ-mercaptoethanol rather than DTT to stop disulphide bridges from forming.  
The MDCC-SSB signal is stable and linear at both high and low concentrations and salt concentrations. 
This study shows the addition of excess ssDNA or ssRNA substrates results in a large fluorescence 
increase of 1.9 and 2.1 fold. This fluorescence increase is not as high as previously quoted from 
Dillingham et al49 in which when MDCC-SSB bound ssDNA a 4.9 fold increase was observed. This 
variation in fluorescence could be down to reduced labelling of SSB monomers in this study in which 
unlabelled monomers as part of the tetramer are still able to bind but do not produce a signal. Also, 
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here, compared to the previous one, a lower salt concentration was used which could result in a 
difference in binding modes of SSB between the studies. For both substrates, the excitation maximum 
and emission maximum occurred at 435nm and 470nm respectively with a Stokes shift of 35nm. The 
fact there is no difference in these peaks implies the ssDNA and ssRNA are binding in similar way and 
are causing the same protein conformation changes leading to a fluorescence increase.  
This result shows the biosensor is capable of reporting on the presence of ssRNA. The fluorescence 
increase occurs in a substrate concentration dependent manner for both the ssRNA and ssDNA 
substrates. Whilst it has previously been proven that this occurs with ssDNA, it was important to use 
the ssDNA as a positive control so as to ensure the biosensor was behaving as expected and that it 
was stable and responding in both high and low salt conditions. There was some difference in the 
saturation point of the biosensor with ssDNA70, at low salt being 64nM and 90nM at high salt, showing 
that the biosensor is responsive in both buffers. The interesting response of the MDCC-SSB is that the 
saturation point occurs at a higher concentration than the expected 50nM. The higher saturation 
points for the ssDNA substrate could be down to the three out of four monomers labelled and the salt 
concentration that might be pushing the SSB into an (SSB)35, in which only two OB-folds bind with the 
substrate. With binding modes being fluid, the MDCC-SSB solution containing the ssDNA could be a 
complex mix of dimers and tetramers in both binding modes. Further work would be required to 
define this cocktail of SSB species using, for example, Size Exclusion Chromatography with Multi-Angle 
Light Scattering (SEC-MALS) anlysis to determine the oligomeric states. To reduce the amount of 
unlabelled monomers still present in the biosensor mix, a gel filtration column could be used with high 
separation that would allow for the isolation of the labelled species only.  
This knowledge can be applied to the higher saturation points observed with ssRNA being at 101nM 
in low salt and 109nM in high salt. Unlike ssDNA these two saturation points seem to be independent 
of the salt concentration. Moreover, as with the thermophoresis, it appears that the (SSB)35 binding 
mode may dominate for the ssRNA substrates.  When ssRNA substrates are at a low concentration 
there is a linear increase in fluorescence before saturation of the biosensor. Saturation is the point at 
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which there is no free biosensor in the system. Calibration of the biosensor required 50nM MDCC-SSB 
in 100mM NaCl buffer. This presented a linear increase of fluorescence starting from 3.9nM of ssRNA70 
up to 101nM of ssRNA70, during this linear phase the MDCC-SSB biosensor ŝƐ “ƐĞŶƐŝƚŝǀĞ ?ĂŶĚŝƐable to 
distinguish between ssRNA concentrations. After saturation occurs, a larger concentration of MDCC-
SSB is necessary to quantify higher concentrations of substrate to invoke a linear fluorescence 
increase. The MDCC-^^ ?ƐƌĞƐƉŽŶƐĞƚŽƐƵďƐƚƌĂƚĞŝƐƐŝŵŝůĂƌƚŽďŽƚŚƐƐEĂŶĚƐZEŝŶǁŚŝĐŚĂůŝŶĞĂƌ 
increase is present at both high and low salt concentration. The biosensor has shown it can be 
calibrated in different buffers and it is suitable for mRNA quantification measurements.  
 
4.3 Application of the biosensor  
 
The MDCC-SSB biosensor is suitable for use as a comparative assay post transcription. Each T7 
polymerase transcription proceeded for a set time period, resulting in different amounts of mRNA 
transcript produced. RT-qPCR allowed for accurate quantification of the mRNA transcripts and the 
MDCC-SSB fluorescence was measured to assess if the fluorescence increase matched the mRNA 
concentration. When the results of the MDCC-SSB fluorescence increase were plotted against RT-qPCR 
quantification, there is a clear linear correlation which shows that samples can be compared against 
each other and there is a clear signal that separates each amount of mRNA. There was a single result 
where high fluorescence increase was witnessed for a small amount of mRNA but this could be 
explained by the loss of mRNA during the RT-qPCR preparation process or ssDNA being present in the 
purified samples. 
 The biosensor does not appear to rely on transcripts that are of specific length. Whilst ssRNA70 was 
used to characterise the biosensor, the post transcription result shows that multiple MDCC-SSB 
proteins are able to bind along the length of the transcripts. To accurately quantify the concentration 
of mRNA, the length of the transcript needs to be known. This knowledge is required to transfer the 
calibration titration of the fluorescence increase, performed with ssRNA70, into a concentration of 
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total transcripts. With transcription in varying conditions i.e. running for different lengths of time, this 
approach is not possible. However, total mRNA concentration can be determined in terms of SSB 
binding sites which are assumed to be 70 bases. This approach is very much similar to quantification 
through RT-qPCR. Therefore, the MDCC-SSB can distinguish between the samples based upon 
absolute differences in the total number of SSB binding sites along transcripts of various lengths. This 
represents a low cost and significantly faster method than current mRNA quantification protocols 
available and it can be used without the need for mRNA purification.  
MDCC-SSB is not suitable for real time analysis of in vitro transcription. Even with the production of 
mRNA there is a decrease of fluorescence over time that cannot be calibrated into the assay. This 
decrease is due to aggregation of MDCC-SSB as shown by the DLS analysis. Further analysis identified 
no loss of structure of MDCC-SSB represented by the CD data and no loss of MDCC fluorescence across 
a three hour incubation period. During the transcription process a greater decease in fluorescence 
occurred for all controls, as well as the assay itself, when single stranded substrates were present in 
solution. This could be due to the MDCC-SSB polymerising with binding as well as aggregating, both of 
which could result in the quenching of the fluorescence signal. This represents a typical limitation of 
using fluorescence reporters whereby numerous factors can contribute to the overall signal. 
This study shows that MDCC-SSB is a suitable biosensor for measuring mRNA concentrations after 
transcription and eliminates the need for incorporation of radioactively labelled nucleotides and gel 
electrophoresis. It can be used to compare conditions without the need for quantification or to 
quantify mRNA concentrations after calibration of the sensor; making it a rapid process capable of 
withstanding different salt buffers. This calibration of MDCC-SSB takes away the need for RT-qPCR, 
which has multiple steps that can all incorporate human error into the protocol. The stability of this 
biosensor means it is able to work without extra reagents and without RNA purification as long as the 
samples do not contain ssDNA.  It is however not suitable to be used in any real time in vitro 
transcription assays due to its ability to aggregate over time and possible polymerisation, both of 
which result in a loss of fluorescence.  With clear evidence that SSB is able to 1) bind mRNA, 2) produce 
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a detectable signal when labelled with MDCC and 3) have an increase in fluorescence dependent on 
mRNA concentration, this study provides a new alternative to classical methods and has successfully 
produced a working mRNA biosensor.   
5. Further Work  
 
- Due to the similar binding patterns observed in the EMSA, the tryptophan quenching and the 
identical Stokes shift it is possible that RNA binds in an identical way to ssDNA. To gain a better 
understanding in the way in which SSB binds to RNA, the method of point mutations within the OB-
fold could identify if the RNA and ssDNA interact with SSB in a similar manner, or if the SSB structure 
has distinct interactions with the RNA.  
- Within this piece of work it was identified that saturation of the biosensor did not occur at equal 
concentrations of the biosensor. This is due to the dimer, tetramer species and different binding 
modes of SSB. An interesting study would be to quantify the SSB species in the sample so as to get a 
better understanding of this delayed saturation.  
- Whilst in this study 50nM SSB was titrated with single stranded substrates, to increase the MDCC-
^^ ?ƐƵƐĞĂƐĂďŝŽƐĞŶƐŽƌŝƚǁŽƵůĚďe ideal to undertake further calibrations of the biosensor at different 
concentrations. This could lead to a database of fluorescence increase ratios relating to mRNA 
concentrations in different buffers. 
- This study used samples of transcription assay that proceeded for various amounts of time. To further 
characterise the biosensor it would be important to use it with post transcription samples that had 
been undertaken in different conditions, such as with the addition of inhibitors or with different 
concentrations of DNA template. 
- Whilst SSB was proven to bind ssRNA, it would be of interest to further identify other well 
characterised proteins that bind to mRNA that are suitable to be fluorescently labelled, leading to 
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changes in fluorescence. This could generate biosensor specific to mRNA that provides reliable results 
even in the presence of ssDNA. 
- Due to the biosensor not being suitable for real time transcription analysis it would be important to 
look at other fluorescent methods for this purpose. One such method could be to measure the 
incorporation of fluorescently labelled nucleotides.  
- MDCC is not appropriate for microscopy due to its photophysical properties, SSB labelled with Cy3b 


























Table 2. RT-qPCR Primers 
Name Sequence 
RecD2 forward GGGTCAACAAAGTCCGTTTC 
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